$SCL

Stepan to Announce Third Quarter 2026 Results on October 28, 2026

Stepan Company (NYSE: SCL) will release its Q3 2026 earnings on October 28, 2026, at 7:00 a.m. ET, with a conference call at 9:00 a.m. ET. The company manufactures specialty chemicals for various industries. Its stock is traded on the NYSE under the symbol SCL.

Original reporting
Published Oct 7, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stepan to Announce Third Quarter 2026 Results on October 28, 2026 — source image
Decision brief

The 30-second read

$SCLNeutralLow
01

Why it matters

The announcement provides a concrete date for traders to plan pre‑earnings positioning. No new financial data is disclosed, so the immediate impact is limited to timing awareness.

02

Market read

A routine earnings‑release schedule with limited immediate trading relevance; primary interest for traders is timing the upcoming Q3 results.

03

What to watch

Analysts may already have expectations for Q3; the real catalyst will be the earnings numbers themselves.

Relevance 4/10Novelty 3/10Timing: pre‑market on Oct 28, 2026

Background

Stepan Company (NYSE: SCL) is a specialty chemicals manufacturer. The press release sets the schedule for its Q3 2026 earnings call.

Company-level read

Ticker impact

$SCLNeutralMedium confidence
Context

Stepan Company announced the date and time of its Q3 2026 earnings release and conference call.

Expected impact

potential short‑term price swing around the release, direction depends on earnings surprise

Evidence & confidence

No financial numbers are disclosed yet; the news is purely a timing announcement, so impact is speculative.

Market effects

None significant; the announcement is specific to Stepan and does not affect the broader chemicals sector.

Limited to U.S. investors tracking Stepan; no broader regional effect.

Minimal, as the news is a routine earnings schedule.

Counterpoint

If the market overreacts to the timing announcement, a contrarian could look for a short‑term pullback after the release.

Key entities

  • Stepan Company

    Specialty chemicals producer announcing Q3 2026 earnings release.

  • Luis E. Rojo

    President and CEO of Stepan, will host the earnings call.

  • Ruben Velasquez

    Senior Vice President and CFO of Stepan, will co‑host the earnings call.

Related articles

$SCLMed

Stepan Company Q2 2026 Earnings Call Summary

Strategic Performance Drivers Adjusted EBITDA growth of 45% was driven by a combination of 6% organic volume growth, disciplined pricing execution, and ramping productivity gains. Surfactant performance benefited from broad-based demand across all end markets, specifically led by industrial cleaning, laundry, and oil field sectors. Margin recovery was achieved through the rigorous application of contractual pass-through mechanisms and pricing actions to offset fluctuating raw material costs.

$SCLMedAI 8/10

Stepan Reports Second Quarter 2026 Results

Stepan (NYSE: SCL) reported Q2 2026 net income of $22.9M, up 102% year over year, and adjusted net income of $27.1M, up 126%. Adjusted EBITDA rose 45% to $74.4M. Net sales increased 15% to $684.1M, with organic volume up 6%. Free cash flow was -$15.0M due to working capital. The company plans to cut about 100 salaried roles under Project Catalyst and expects full-year restructuring charges of $75.0M-$80.0M.

$SCLMed

Stepan Reports Second Quarter 2026 Results

STEPAN CO (SCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stepan Reports Second Quarter 2026 Results Northbrook, Illinois, July 29, 2026 — Stepan Company (NYSE: SCL) today reported: Second Quarter 2026 Highlights • Reported net income was $22.9 million, up 102% versus the prior year. Adjusted net income (1) was $27.1 millio

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.

$SCLHighAI 9/10

Daily NZX update, Wednesday, May 27, 2026

The NZX50 rose 0.7% to extend gains to 3.1% over five days and 3.1% for the month (still down 2.0% over six months; up 4.6% YoY). Kathmandu Holdings jumped 14% and KMD reported Q3 FY26 sales +5.2% YoY and gross margin 58.2% (+258 bps). Vista Group gained 4% on a new five-year Cinemex deal; PaySauce revenue rose 3% to $9.2m.